
The Respiratory Bacterial Panel Strip kit is an advanced, professional tool for the detection of a molecular panel of 14 bacteria responsible for respiratory infections. From respiratory tract samples (swabs, washings, nasopharyngeal aspirates, sputum, etc.), it allows the identification of key pathogens such as Streptococcus pneumoniae, Bordetella pertussis, B. parapertussis, B. holmesii, Legionella spp. (including L. pneumophila, L. micdadei, L. longbeachae, L. bozemanae), Mycoplasma pneumoniae, Chlamydophila pneumoniae, Haemophilus influenzae (differentiating serotype b from non-b) and Moraxella catarrhalis.
Acute respiratory infections represent a major public health problem worldwide, accounting for 30-40% of paediatric hospital admissions. Their impact is especially critical in children, older adults and immunocompromised patients. The difficulty in distinguishing between viral and bacterial pathogens on the basis of symptomatology alone (common cold, bronchitis, bronchiolitis, sinusitis, pneumonia, etc.) can delay diagnosis and affect the choice of treatment.
Rapid and accurate molecular diagnosis with the Respiratory Bacterial Panel Strip is key to improving the management of these infections. It allows identification of the causative agent and differentiation of viral or bacterial origin, which optimises the use of antimicrobials and helps to reduce bacterial resistance. In addition, its implementation in hospitals, clinics and laboratories helps to reduce the duration of hospitalisations, apply timely isolation measures and collect real-time data for epidemiological studies on the seasonal spread of pathogens.
14 analytes in the same strip
Possibility to automate the hybridization process
COD-UNG system for avoiding contaminations
Differentiation of Legionella, Bordetella and Haemophilus species/types
Several types of sample validated
Detection of 14 of the most common pathogens causing respiratory tract diseases in a single strip. In addition, the test differentiates the most relevant strains of Legionella and Bordetella, as well as H. influenzae serotype b, very useful for detecting vaccination failure or absence of vaccination.
Several samples validated: pleural liquid, nasopharyngeal and bronchoalveolar swab/washes/aspirates, sputum, nasopharyngeal swab, conjunctival smear and optic swab. This allows a better diagnosis of the patient, as the professional can take the sample directly from the area where the patient has the most symptoms, resulting in greater sensitivity and effectiveness of the test.
The use of the COD-UNG system reduces the possibility of contamination after the hybridization process, ensuring a reliable and sensitive result. However, precautions must be taken to ensure that amplified DNA fragments do not come into contact with future PCR reactions.
High sensitivity for pathogens commonly found in the respiratory tract, allowing diagnosis of their infection in specimens that should be sterile, even when found in very low concentrations. Detection of these micro-organisms in non-sterile specimens should be considered on the basis of symptoms and other patient findings.
No, the minimum amount present in the sample is detected, which allows its detection in sterile samples even if they are in low concentration. Detection of these microorganisms in non-sterile samples should be considered in function of symptoms and other patient findings.
In principle, any extraction method that provides quality DNA can be used. However, some extraction kits based on silica columns may be contaminated with Legionella, which can lead to false positives. It is recommended to extract blanks before using real samples to confirm the usefulness of the extraction method.